CARDINAL HEALTH INC
CAHNYSE · SIC 5122
$228.52
↓ -0.1%Jul 17 close · end-of-day
Price
1Y↑ +43.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$54.2B
Enterprise Value
$60.4B
P/E
—
P/S
0.2
P/B
—
EV/EBITDA
17.7
PEG
—
FCF Yield
10.2%
Dividend Yield
0.9%
Revenue (TTM)
$244.7B
Net Income (TTM)
$1.7B
Free Cash Flow (TTM)
$5.5B
Gross Margin
3.7%
Operating Margin
1.0%
Net Margin
0.7%
ROE
-57.6%
ROIC
55.4%
Debt / Equity
-3.1
Net Cash
-$6.3B
Return 1Y
+44.8%
Company profile
Cardinal Health, Inc. operates in two segments, Pharmaceutical and Medical. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products.
- CEO
- Jason M. Hollar
- Sector
- Wholesale Trade
- Industry
- Wholesale
- Employees
- 46,500
- Headquarters
- Ohio
- Website
- cardinalhealth.com
Management & directors
- Greene Michelle D.Chief Information Officer
- Alt Aaron EChief Financial Officer
- Pitteroff Valerie ChristineChief Human Resources Officer
- Mason Stephen MCEO, GMPD Segment
- Mayer Jessica LChief Legal/Compliance Officer
- Scherer Mary C.Chief Accounting Officer
- Snow Ola MChief Human Resources Officer
- Weitzman DeborahCEO, PSS Segment
- Hollar Jason M.Chief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
Next earnings · estimated2026-07-30
CAH Q2 2025 Earnings
Period ends 2025-12-31
MetricActualYoY
Revenue$65.6B↑ +18.8%
Diluted EPS——
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $162.5B | $181.3B | $205.0B | $226.8B | $222.6B |
| Gross profit | $6.8B | $6.5B | $6.9B | $7.4B | $8.2B |
| Operating income | $472.0M | -$607.0M | $752.0M | $1.2B | $2.3B |
| Net income | $611.0M | -$938.0M | $330.0M | $852.0M | $1.6B |
| Diluted EPS | $2.08 | -$3.37 | $1.26 | $3.45 | $6.45 |
| Operating cash flow | $2.4B | $3.2B | $2.8B | $3.8B | $2.4B |
| Free cash flow | $2.0B | $2.8B | $2.4B | $3.3B | $1.9B |
| Gross margin | 4.2% | 3.6% | 3.4% | 3.3% | 3.7% |
| Operating margin | 0.3% | -0.3% | 0.4% | 0.5% | 1.0% |
| Net margin | 0.4% | -0.5% | 0.2% | 0.4% | 0.7% |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $54.9B | $59.9B | $52.3B | $55.3B | $54.9B | $60.2B | $64.0B | $65.6B |
| Gross profit | $1.9B | $1.9B | $1.9B | $1.9B | $2.1B | $2.2B | $2.3B | $2.4B |
| Operating income | $369.0M | $401.0M | $568.0M | $549.0M | $730.0M | $428.0M | $668.0M | $707.0M |
| Net income | $261.0M | $235.0M | $416.0M | $400.0M | $506.0M | $239.0M | $450.0M | $467.0M |
| Diluted EPS | $1.07 | $0.93 | $1.70 | — | — | — | $1.88 | — |
| Operating cash flow | -$27.0M | $2.1B | -$1.6B | -$396.0M | $2.9B | $1.5B | $973.0M | $686.0M |
| Free cash flow | -$139.0M | $1.9B | -$1.7B | -$495.0M | $2.8B | $1.3B | $865.0M | $555.0M |
| Gross margin | 3.5% | 3.1% | 3.6% | 3.5% | 3.9% | 3.7% | 3.6% | 3.7% |
| Operating margin | 0.7% | 0.7% | 1.1% | 1.0% | 1.3% | 0.7% | 1.0% | 1.1% |
| Net margin | 0.5% | 0.4% | 0.8% | 0.7% | 0.9% | 0.4% | 0.7% | 0.7% |
Company news
Jul 20, 2026
Jul 17, 2026
- 3d agoReasons to Retain Doximity Stock in Your Portfolio for Nowfinance.yahoo.com
- 3d agoISRG Q2 Earnings Beat Estimates, Stock Falls on Slow Procedure Growthfinance.yahoo.com
- 3d agoStryker Launches Mako RPS to Expand Robotic Knee Surgery Portfoliofinance.yahoo.com
- 3d agoHere's Why You Should Retain INSP Stock in Your Portfolio for Nowfinance.yahoo.com
- 3d agoWill Declining Membership Affect Molina Healthcare's Q2 Earnings?finance.yahoo.com
- 3d agoGEHC Stock Up on $500M Strategic Care Alliance With Catholic Healthfinance.yahoo.com
Jul 16, 2026
- 4d agoReasons to Retain Cooper Companies Stock in Your Portfolio for Nowfinance.yahoo.com
- 4d agoCan Higher Occupancy Offset Lower Admissions in CYH's Q2 Earnings?finance.yahoo.com
- 4d agoDanaher Gears Up to Post Q2 Earnings: Is a Beat in the Offing?finance.yahoo.com
- 4d agoSmith+Nephew Launches LYNX COBLATION Wand for ENT Airway Surgeryfinance.yahoo.com
- 4d agoReasons to Hold HealthEquity Stock in Your Portfolio for Nowfinance.yahoo.com
- 4d agoFractyl Health Stock Up on Encouraging One-Year Revita Study Resultsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-04-15 | Hall Patricia Hemingway | Award | 381 | $207.83 | $79,183.23 | filing |
| 2026-02-27 | Greene Michelle D.· Chief Information Officer | Sale | 2,646 | $228.47 | $604,531.62 | filing |
| 2026-02-27 | Greene Michelle D.· Chief Information Officer | Sale | 100 | $228.55 | $22,855.00 | filing |
| 2026-02-18 | Alt Aaron E· Chief Financial Officer | Sale | 2,328 | $225.50 | $524,964.00 | filing |
| 2026-02-15 | Alt Aaron E· Chief Financial Officer | Tax withholding | 1,914 | $220.79 | $422,592.06 | filing |
| 2026-02-06 | Hall Patricia Hemingway | Sale | 4,000 | $229.72 | $918,880.00 | filing |
| 2026-01-15 | Pitteroff Valerie Christine· Chief Human Resources Officer | Award | 3,982 | $213.26 | $849,201.32 | filing |
| 2025-12-01 | Mason Stephen M· CEO, GMPD Segment | Tax withholding | 595 | $212.26 | $126,294.70 | filing |
| 2025-12-01 | WEITZMAN DEBORAH· CEO, PSS Segment | Tax withholding | 551 | $212.26 | $116,955.26 | filing |
| 2025-12-01 | Mayer Jessica L· Chief Legal/Compliance Officer | Tax withholding | 422 | $212.26 | $89,573.72 | filing |
| 2025-12-01 | Snow Ola M· Chief Human Resources Officer | Tax withholding | 320 | $212.26 | $67,923.20 | filing |
| 2025-12-01 | Scherer Mary C.· Chief Accounting Officer | Tax withholding | 61 | $212.26 | $12,947.86 | filing |
| 2025-11-05 | Musslewhite Robert W | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Ramakrishna Sudhakar | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | MUNDKUR CHRISTINE | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Killefer Nancy | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | KENNY GREGORY B | Award | 1,702 | $0.00 | $0.00 | filing |
| 2025-11-05 | JOHRI AKHIL | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Hall Patricia Hemingway | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Evans David C | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Edison Sheri H. | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Brennan Michelle | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-11-05 | Azelby Robert | Award | 1,067 | $0.00 | $0.00 | filing |
| 2025-08-20 | Hollar Jason M.· Chief Executive Officer | Sale | 22,957 | $150.40 | $3.5M | filing |
| 2025-08-20 | WEITZMAN DEBORAH· CEO, PSS Segment | Sale | 21,367 | $150.53 | $3.2M | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.